Standard BioTools PE Ratio 2010-2024 | LAB
Current and historical p/e ratio for Standard BioTools (LAB) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Standard BioTools PE ratio as of March 11, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Standard BioTools PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-03-11 |
1.14 |
|
0.00 |
| 2024-09-30 |
1.93 |
$-0.71 |
0.00 |
| 2024-06-30 |
1.77 |
$-0.91 |
0.00 |
| 2024-03-31 |
2.71 |
$-1.01 |
0.00 |
| 2023-12-31 |
2.21 |
$-0.95 |
0.00 |
| 2023-09-30 |
2.90 |
$-0.96 |
0.00 |
| 2023-06-30 |
1.93 |
$-1.06 |
0.00 |
| 2023-03-31 |
1.95 |
$-1.66 |
0.00 |
| 2022-12-31 |
1.17 |
$-2.44 |
0.00 |
| 2022-09-30 |
1.10 |
$-2.30 |
0.00 |
| 2022-06-30 |
1.60 |
$-2.11 |
0.00 |
| 2022-03-31 |
3.59 |
$-1.52 |
0.00 |
| 2021-12-31 |
3.92 |
$-0.78 |
0.00 |
| 2021-09-30 |
6.59 |
$-0.90 |
0.00 |
| 2021-06-30 |
6.16 |
$-0.80 |
0.00 |
| 2021-03-31 |
4.52 |
$-0.75 |
0.00 |
| 2020-12-31 |
6.00 |
$-0.73 |
0.00 |
| 2020-09-30 |
7.43 |
$-0.67 |
0.00 |
| 2020-06-30 |
4.01 |
$-0.78 |
0.00 |
| 2020-03-31 |
2.54 |
$-0.80 |
0.00 |
| 2019-12-31 |
3.48 |
$-1.01 |
0.00 |
| 2019-09-30 |
4.63 |
$-1.19 |
0.00 |
| 2019-06-30 |
12.32 |
$-1.38 |
0.00 |
| 2019-03-31 |
13.29 |
$-1.60 |
0.00 |
| 2018-12-31 |
8.62 |
$-1.50 |
0.00 |
| 2018-09-30 |
7.49 |
$-1.41 |
0.00 |
| 2018-06-30 |
5.96 |
$-1.49 |
0.00 |
| 2018-03-31 |
5.84 |
$-1.65 |
0.00 |
| 2017-12-31 |
5.89 |
$-1.90 |
0.00 |
| 2017-09-30 |
5.04 |
$-2.24 |
0.00 |
| 2017-06-30 |
4.04 |
$-2.46 |
0.00 |
| 2017-03-31 |
5.69 |
$-2.52 |
0.00 |
| 2016-12-31 |
7.28 |
$-2.62 |
0.00 |
| 2016-09-30 |
8.01 |
$-2.46 |
0.00 |
| 2016-06-30 |
9.03 |
$-2.10 |
0.00 |
| 2016-03-31 |
8.07 |
$-1.99 |
0.00 |
| 2015-12-31 |
10.81 |
$-1.86 |
0.00 |
| 2015-09-30 |
8.11 |
$-1.80 |
0.00 |
| 2015-06-30 |
24.20 |
$-1.97 |
0.00 |
| 2015-03-31 |
42.10 |
$-1.89 |
0.00 |
| 2014-12-31 |
33.73 |
$-1.90 |
0.00 |
| 2014-09-30 |
24.50 |
$-1.66 |
0.00 |
| 2014-06-30 |
29.40 |
$-1.34 |
0.00 |
| 2014-03-31 |
44.07 |
$-1.05 |
0.00 |
| 2013-12-31 |
38.28 |
$-0.62 |
0.00 |
| 2013-09-30 |
21.94 |
$-0.61 |
0.00 |
| 2013-06-30 |
17.46 |
$-0.62 |
0.00 |
| 2013-03-31 |
18.51 |
$-0.68 |
0.00 |
| 2012-12-31 |
14.31 |
$-0.87 |
0.00 |
| 2012-09-30 |
17.00 |
$-0.90 |
0.00 |
| 2012-06-30 |
15.04 |
$-0.94 |
0.00 |
| 2012-03-31 |
15.73 |
$-1.08 |
0.00 |
| 2011-12-31 |
13.16 |
$-2.35 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.495B |
$0.106B |
|
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
|
